We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
Industry Pages™ is a free annual report produced by OCT Clinical for pharmaceutical industry experts.
It collates data from numerous public sources into a single brief document, the aim of which is to aid decision makers who are planning to conduct clinical trials in Eastern Europe. The Industry Pages report will enable readers to understand and gain insights into the clinical research market in Eastern Europe, along with its landscape, key players and emerging trends.
The U.S. Food and Drug Administration (FDA) published its Novel Drug Approvals Report for 2021. 33 out of 50 drugs underwent clinical trials in Eastern Europe. Read the annual Industry Pages report, prepared by OCT Clinical, a European CRO, to find out why global pharma considers the region as the best destination for their clinical research activities.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
